Outcomes of Hospital-Acquired Hypernatremia.
Journal
Clinical journal of the American Society of Nephrology : CJASN
ISSN: 1555-905X
Titre abrégé: Clin J Am Soc Nephrol
Pays: United States
ID NLM: 101271570
Informations de publication
Date de publication:
01 11 2023
01 11 2023
Historique:
received:
07
02
2023
accepted:
05
09
2023
pmc-release:
01
11
2024
medline:
9
11
2023
pubmed:
19
9
2023
entrez:
18
9
2023
Statut:
ppublish
Résumé
Hospital-acquired hypernatremia is highly prevalent, overlooked, and associated with unfavorable consequences. There are limited studies examining the outcomes and discharge dispositions of various levels of hospital-acquired hypernatremia in patients with or without CKD. We conducted an observational retrospective cohort study, and we analyzed the data of 1,728,141 patients extracted from the Cerner Health Facts database (January 1, 2000, to June 30, 2018). In this report, we investigated the association between hospital-acquired hypernatremia (serum sodium [Na] levels >145 mEq/L) and in-hospital mortality or discharge dispositions with kidney function status at admission using adjusted multinomial regression models. Of all hospitalized patients, 6% developed hypernatremia after hospital admission. The incidence of in-hospital mortality was 12% and 1% in patients with hypernatremia and normonatremia, respectively. The risk of all outcomes was significantly greater for serum Na >145 mEq/L compared with the reference interval (serum Na, 135-145 mEq/L). In patients with hypernatremia, odds ratios (95% confidence interval) for in-hospital mortality, discharge to hospice, and discharge to nursing facilities were 14.04 (13.71 to 14.38), 4.35 (4.14 to 4.57), and 3.88 (3.82 to 3.94), respectively ( P < 0.001, for all). Patients with eGFR (Chronic Kidney Disease Epidemiology Collaboration) 60-89 ml/min per 1.73 m 2 and normonatremia had the lowest odds ratio for in-hospital mortality (1.60 [1.52 to 1.70]). Hospital-acquired hypernatremia is associated with in-hospital mortality and discharge to hospice or to nursing facilities in all stages of CKD.
Sections du résumé
BACKGROUND
Hospital-acquired hypernatremia is highly prevalent, overlooked, and associated with unfavorable consequences. There are limited studies examining the outcomes and discharge dispositions of various levels of hospital-acquired hypernatremia in patients with or without CKD.
METHODS
We conducted an observational retrospective cohort study, and we analyzed the data of 1,728,141 patients extracted from the Cerner Health Facts database (January 1, 2000, to June 30, 2018). In this report, we investigated the association between hospital-acquired hypernatremia (serum sodium [Na] levels >145 mEq/L) and in-hospital mortality or discharge dispositions with kidney function status at admission using adjusted multinomial regression models.
RESULTS
Of all hospitalized patients, 6% developed hypernatremia after hospital admission. The incidence of in-hospital mortality was 12% and 1% in patients with hypernatremia and normonatremia, respectively. The risk of all outcomes was significantly greater for serum Na >145 mEq/L compared with the reference interval (serum Na, 135-145 mEq/L). In patients with hypernatremia, odds ratios (95% confidence interval) for in-hospital mortality, discharge to hospice, and discharge to nursing facilities were 14.04 (13.71 to 14.38), 4.35 (4.14 to 4.57), and 3.88 (3.82 to 3.94), respectively ( P < 0.001, for all). Patients with eGFR (Chronic Kidney Disease Epidemiology Collaboration) 60-89 ml/min per 1.73 m 2 and normonatremia had the lowest odds ratio for in-hospital mortality (1.60 [1.52 to 1.70]).
CONCLUSIONS
Hospital-acquired hypernatremia is associated with in-hospital mortality and discharge to hospice or to nursing facilities in all stages of CKD.
Identifiants
pubmed: 37722368
doi: 10.2215/CJN.0000000000000250
pii: 01277230-202311000-00006
pmc: PMC10637455
doi:
Substances chimiques
Sodium
9NEZ333N27
Types de publication
Observational Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1396-1407Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Society of Nephrology.
Références
Sci Rep. 2017 Nov 21;7(1):15949
pubmed: 29162909
Intern Emerg Med. 2021 Apr;16(3):617-624
pubmed: 32776204
Am J Epidemiol. 2011 Mar 15;173(6):676-82
pubmed: 21330339
Med Sci Monit. 2012 Dec;18(12):CR729-34
pubmed: 23197235
Am J Kidney Dis. 2022 Feb;79(2):268-288.e1
pubmed: 34563581
Ann Intern Med. 1996 Jan 15;124(2):197-203
pubmed: 8533994
N Engl J Med. 2000 May 18;342(20):1493-9
pubmed: 10816188
Adv Chronic Kidney Dis. 2016 Jul;23(4):240-6
pubmed: 27324677
Neth J Med. 2015 Dec;73(10):448-54
pubmed: 26687260
Med Sci Monit. 2017 May 21;23:2408-2425
pubmed: 28528344
Am J Kidney Dis. 2020 Feb;75(2):272-286
pubmed: 31606238
BMC Med Inform Decis Mak. 2017 Nov 22;17(1):152
pubmed: 29166900
J Crit Care. 2013 Aug;28(4):405-12
pubmed: 23369520
Contrib Nephrol. 2018;196:229-236
pubmed: 30041232
Am J Med. 1999 Apr;106(4):399-403
pubmed: 10225241
Medicine (Baltimore). 2016 Aug;95(35):e3840
pubmed: 27583842
Am J Nephrol. 2015;41(3):200-9
pubmed: 25871915
Circulation. 2012 Feb 7;125(5):677-84
pubmed: 22223429
Nephrology (Carlton). 2016 Jun;21(6):476-82
pubmed: 26426983
Intensive Care Med. 2010 Feb;36(2):304-11
pubmed: 19847398
BMC Nephrol. 2016 Jan 05;17:2
pubmed: 26732402
J Am Med Inform Assoc. 1998 May-Jun;5(3):276-92
pubmed: 9609498
Medicina (Kaunas). 2020 Jul 17;56(7):
pubmed: 32709029
Nephron Clin Pract. 2012;120(4):c179-84
pubmed: 22890468
Am J Med. 2018 Jan;131(1):72-82.e1
pubmed: 28860033
Nephrol Dial Transplant. 2012 Mar;27(3):891-8
pubmed: 22379183
N Engl J Med. 1973 Oct 18;289(16):843-4
pubmed: 4763428
Support Care Cancer. 2013 Jul;21(7):1871-8
pubmed: 23404230
Am J Med. 2013 Mar;126(3):256-63
pubmed: 23332973
Front Med (Lausanne). 2021 Dec 06;8:769287
pubmed: 34938749